ProdIgy Biotech | Finanzwire

Basculer en Français

11230	Companies
249094	Keywords
177020	Articles
134928	Press releases

Home
Companies
ProdIgy Biotech

PRESS RELEASE

published on 02/06/2024 at 16:00, 2 years 8 months ago

PRODIGY BIOTECH ENTERS INTO A PARTNERSHIP AGREEMENT WITH LEADING CANCER CENTER TO ADVANCE PRODUCTS TO IMPROVE OUTCOMES IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Prodigy Biotech partners with leading cancer center MSK to develop products improving outcomes in patients undergoing allogenic hematopoietic stem cell transplantation. The collaboration aims to evaluate a product targeting Enterococcus sp. to treat microbial dysbiosis and reset the gut microbiome, potentially mitigating disease severity

Prodigy Biotech MSK Cancer Center Allogenic Hematopoietic Stem Cell Transplantation Microbial Dysbiosis

Accesswire

Published on 10/26/2026 at 23:00, 14 minutes ago

American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 1 hour 14 minutes ago

IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/26/2026 at 22:00, 1 hour 14 minutes ago

Alset AI Announces Non-Brokered Private Placement Offering of a Minimum of $650,000 and a Maximum of $800,000
Published on 10/26/2026 at 21:30, 1 hour 44 minutes ago

Clean Air Metals Announces Auditor Review of Q2 Financial Statements
Published on 10/26/2026 at 14:10, 9 hours 4 minutes ago

China XLX Announces 2026 9M Results

View all ACCESSWIRE

EQS Group

Published on 10/26/2026 at 22:23, 51 minutes ago

EQS-Adhoc: SMAG Mobile Antenna Masts AG: Changes to the Management Board
Published on 10/26/2026 at 21:57, 1 hour 16 minutes ago

EQS-Adhoc: PAUL Tech AG: Noteholders’ Meeting in respect of the EUR 35 million notes resolves on extension of the term of the notes
Published on 10/26/2026 at 21:32, 1 hour 41 minutes ago

UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT
Published on 10/26/2026 at 20:00, 3 hours 13 minutes ago

EQS-Adhoc: Hypoport SE: Gross profit growth and increase in EBIT in Q1-Q3 2026
Published on 10/26/2026 at 19:10, 4 hours 4 minutes ago

PolyPeptide announces results of the extraordinary general meeting of shareholders

Les Echos

Published on 10/26/2026 at 18:11, 5 hours 3 minutes ago

Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 17:45, 5 hours 29 minutes ago

Weekly share buyback
Published on 10/26/2026 at 17:30, 5 hours 44 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026
Published on 10/26/2026 at 07:30, 15 hours 44 minutes ago

EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/23/2026 at 20:33, 3 days 2 hours ago

Disclosure of transactions in own shares from October 19 to October 23, 2026

View all LES ECHOS COMFI WIRE